Bavarian Nordic will continue to handle sales and production of the Chikungunya vaccine for Western markets. (Archive photo). Photo: Bavarian Nordic/Reuters
Bavarian Nordic in vaccine deal for fever virus
Danish pharmaceutical company Bavarian Nordic has received approval from US health authorities for its chikungunya virus vaccine. The European Medicines Agency’s committee also recommended approval in Europe. To widen vaccine access, Bavarian Nordic partnered with Indian company Biological E....
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?